Pentavac PFS/SD

pentavac sd/pfsrndiphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus type b conjugate vaccine (adsorbed) i.p. Indicationrnfor the prevention of serious childhood diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis b and haemophilus influenzae type b. Route of administrationrnintramuscular injection. Immunization schedulernfirst dose is given at 6 weeks or 10 weeks or 14 weeks of age second dose is given anytime between 12-18 months of age compositionrneach dose of 0.5 ml containsrndiphtheria toxoid � 25 lf (� 30 iu)rntetanus toxoid � 2.5 lf (� 40 iu)rnb. Pertussis (whole cell) � 16 ou (� 4.0 iu)*rnhbsag (rdna) � 10 mcgrnpurified capsular hib polysaccharide (prp)rnconjugated to tetanus toxoid (carrier protein) 10 mcgrn+++ adsorbed on aluminium phosphate, al � 1.25 mgrnpreservative: thiomersal 0.005% *the lower fiducial limit (p=0.95) of the estimated potency is not less than 2.0 iu. Adsorbed can be given at the age of 15-18 months. presentation:rnpentavac sd: 1 dose vial of 0.5 mlrnpentavac pfs: 1 x 0.5 ml - 1 dose pre-filled syringe